96 related articles for article (PubMed ID: 23429762)
21. Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive Disorder.
Lee KY; Jeong SH; Kim SH; Ahn YM; Kim YS; Jung HY; Bang YW; Joo EJ
Psychiatry Investig; 2014 Apr; 11(2):192-9. PubMed ID: 24843376
[TBL] [Abstract][Full Text] [Related]
22. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism.
Zhou Z; Lu T; Xu G; Yue X; Zhu W; Ma M; Liu W; Zhu S; Liu X
Clin Chem Lab Med; 2011 Feb; 49(2):185-9. PubMed ID: 21143020
[TBL] [Abstract][Full Text] [Related]
23. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.
Ozan E; Okur H; Eker C; Eker OD; Gönül AS; Akarsu N
Brain Res Bull; 2010 Jan; 81(1):61-5. PubMed ID: 19589373
[TBL] [Abstract][Full Text] [Related]
24. BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuse.
van der Meij A; Comijs HC; Dols A; Janzing JG; Oude Voshaar RC
Psychoneuroendocrinology; 2014 May; 43():81-9. PubMed ID: 24703173
[TBL] [Abstract][Full Text] [Related]
25. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
Froud A; Murphy J; Cribb L; Ng CH; Sarris J
Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
[TBL] [Abstract][Full Text] [Related]
26. Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis.
Yan T; Wang L; Kuang W; Xu J; Li S; Chen J; Yang Y
Asia Pac Psychiatry; 2014 Sep; 6(3):241-51. PubMed ID: 25231750
[TBL] [Abstract][Full Text] [Related]
27. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
[TBL] [Abstract][Full Text] [Related]
28. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
[TBL] [Abstract][Full Text] [Related]
29. Effect of genetic polymorphism of brain-derived neurotrophic factor and serotonin transporter on smoking phenotypes: A pilot study of Japanese participants.
Ohmoto M; Takahashi T
Heliyon; 2019 Feb; 5(2):e01234. PubMed ID: 30815604
[TBL] [Abstract][Full Text] [Related]
30. BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.
Alexopoulos GS; Glatt CE; Hoptman MJ; Kanellopoulos D; Murphy CF; Kelly RE; Morimoto SS; Lim KO; Gunning FM
J Affect Disord; 2010 Sep; 125(1-3):262-8. PubMed ID: 20346518
[TBL] [Abstract][Full Text] [Related]
31. An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.
Kious BM; Sabic H; Sung YH; Kondo DG; Renshaw P
J Clin Psychopharmacol; 2017 Oct; 37(5):578-583. PubMed ID: 28787372
[TBL] [Abstract][Full Text] [Related]
32. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
33. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
[TBL] [Abstract][Full Text] [Related]
34. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
35. Interaction between job stress and the BDNF Val66Met polymorphism affects depressive symptoms in Chinese healthcare workers.
He SC; Wu S; Wang C; Du XD; Yin G; Jia Q; Zhang Y; Wang L; Soares JC; Zhang XY
J Affect Disord; 2018 Aug; 236():157-163. PubMed ID: 29734099
[TBL] [Abstract][Full Text] [Related]
36. Elevated Serum Brain-Derived Neurotrophic Factor (BDNF) but not BDNF Gene Val66Met Polymorphism Is Associated with Autism Spectrum Disorders.
Meng WD; Sun SJ; Yang J; Chu RX; Tu W; Liu Q
Mol Neurobiol; 2017 Mar; 54(2):1167-1172. PubMed ID: 26820673
[TBL] [Abstract][Full Text] [Related]
37. Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.
Yoshimura R; Kishi T; Hori H; Katsuki A; Sugita-Ikenouchi A; Umene-Nakano W; Atake K; Iwata N; Nakamura J
Psychiatry Investig; 2014 Jan; 11(1):84-8. PubMed ID: 24605128
[TBL] [Abstract][Full Text] [Related]
38. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
[TBL] [Abstract][Full Text] [Related]
39. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
[TBL] [Abstract][Full Text] [Related]
40. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
